In this talk, we will explore the challenges of translating the value of Continuous Integration (CI) from the innovation side (R&D) to the business side. We will discuss strategies to effectively communicate the benefits of CI, including faster time-to-market and improved product quality, to stakeholders and decision-makers. Additionally, we will highlight best practices for measuring and quantifying the ROI of CI investments to maximize business value.

In this presentation, you will learn:

• How CI can react on changes in R&D strategies and contribute to adapt a new drug development process,
• What challenges there are for R&D in the Neurology & Neuropsychiatry space.